机译:12周的双盲随机化多中心研究患有严重的广泛焦虑症的Out-患者患者的疗效和安全性的疗效和安全性(25-50?mg /天)
University of Cape Town Department of Psychiatry &
MRC Unit on Risk and Resilience in Mental;
Toowong Specialist Clinic – Level 2;
Mehilainen Clinic Runeberginkatu;
Institute of Psychiatry and Neurology 3rd Department of Psychiatry;
Department of Psychiatry and Behavioural Neurosciences McMaster University;
Private Psychiatric Practice – Vavru?ová Consulting s.r.o;
National Institute of Mental Health;
Department of Psychiatry and Psychotherapy University Hospital Carl Gustav Carus;
Department of Psychiatry and Psychotherapy Semmelweis University;
Department for Therapy of Mental Disorders Moscow Research Institute of Psychiatry;
Institut de Recherches Internationales Servier (IRIS) 50 rue Carnot;
Institut de Recherches Internationales Servier (IRIS) 50 rue Carnot;
Institut de Recherches Internationales Servier (IRIS) 50 rue Carnot;
Institut de Recherches Internationales Servier (IRIS) 50 rue Carnot;
Agomelatine; Escitalopram; Generalized anxiety disorder;
机译:12周的双盲随机化多中心研究患有严重的广泛焦虑症的Out-患者患者的疗效和安全性的疗效和安全性(25-50?mg /天)
机译:Agomelatine的疗效和安全性25-50毫克/天与eSCITALOPRAM 10-20 mg /天在严重的广泛焦虑症
机译:Agomelatine(10或25毫克/天)在非抑郁的外焦虑症患者中的讲解和安全性:12周,双盲,安慰剂对照研究
机译:开放标签,多中心,随机,比较,安全,疗效,循环控制和CTR 25,Alesse和Ortho Tri-Cyclen的生命研究
机译:PS89。焦虑症状对重度抑郁症患者神经认知功能改善的影响:一项为期12周的多肽田奈汀与依他普仑随机试验CAMPION研究
机译:广义焦虑症非抑郁患者的长期疗效和治疗症的安全性。一个26周的随机双盲安慰剂控制并行组在含有胍盐碱的开放标签期间(25毫克/天,致盲剂量调节至50毫克/天)